Global Peripheral Vascular Devices Market - 2020-2027
|出版日期||內容資訊||英文 180 Pages
|末梢血管設備的全球市場 (2020年∼2027年) Global Peripheral Vascular Devices Market - 2020-2027|
|出版日期: 2021年05月10日||內容資訊: 英文 180 Pages||
Peripheral vascular devices are used for the treatment of peripheral vascular diseases, which are slow and progressive blood circulation disorders caused by blockages, narrowing, or spasms in blood vessels outside the heart and brain, including arteries and veins. These devices are classified into peripheral vascular stents, percutaneous transluminal angioplasty balloons, PTA drug-eluting balloons, embolic protection devices, inferior vena cava filters, Aortic stent-grafts, synthetic surgical grafts, and peripheral guide wires.
The global peripheral vascular devices market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).
The peripheral vascular devices market is projected to grow during the review period on account of the growing global geriatric population and respiratory disorders, technological advancements, and increasing lifestyle diseases is expected to boost the peripheral vascular devices market in the following years. The developing markets such as China, Singapore, India, and Brazil are likely to register high growth in the following years to come due to the presence of poor regulatory policies and limited competition. To leverage the high-growth opportunities in these markets, product manufacturers are strategically aiming to expand their presence in these emerging countries. Further, the rising competition in mature markets is further compelling players to focus on developing markets. The demand for medical devices in these countries is growing at a healthy rate when compared to developed countries, thus propelling the product demand.
The medical instruments business in developing economies is increasing significantly owing to the expansion of the private healthcare sector to cater to the needs of the growing middle-class population as well as the rising disposable incomes. The middle-class population in the Asia Pacific is projected to rise from 28% in 2009 to 66% by 2030. As a result of these trends, an increasing number of people in countries such as India and China can afford advanced treatments, including peripheral vascular diseases.
Rapid growth in the geriatric population
The sudden growth in the geriatric population is one of the factors driving the demand for peripheral vascular devices as this population segment is at a high risk of developing peripheral vascular diseases such as atherosclerosis and aneurysms. This is because age, genetic, and lifestyle factors lead to a buildup of plaque in the arteries. Globally, it is estimated that more than 200 million people are suffering from peripheral vascular diseases. Also, the prevalence of these diseases rises with an increase in age and is greater than 20% in the patient population aged above 80 years.
Technological advancement to boost the global peripheral vascular diseases market
The technological advancements in interventional devices, including stents and balloons, are expected to boost interventional cardiology & peripheral vascular devices market revenue. The manufacturing firms are increasing R&D expenditure to achieve sustainable competitiveness through innovation and development in their offerings. This will result into an increase in demand for advanced products to enhance the patient experience. Integrating nanotechnology and drug-eluting stents results in improving treatment efficiency.
COVID-19 Impact Analysis
COVID-19 pandemic has negatively affected the world economy by directly affecting production and demand, supply chain disruption, and financial impact. COVID-19 has adversely impacted the supply chain of suppliers and product manufacturers across the globe. In addition, the production sites shut down to prevent the risk of virus spread. Also, due to the lockdown in many countries, patient visits to hospitals have reduced significantly. Consequently, the number of diagnostic tests has plummeted. This has further reduced the sales of peripheral vascular devices. The overall increase in the prevalence of the peripheral vascular disease is expected to drive the peripheral vascular devices market size in the global market during the forecast period.
Based on the type, the peripheral vascular devices market has been classified into peripheral vascular stents, percutaneous transluminal angioplasty balloons, catheters, PTA guide wires, Atherectomy devices, chronic total acclusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.
Peripheral Vascular Stents segment accounted for significant market share
The peripheral vascular stents segment recorded significant market share for the global peripheral vascular devices market, mainly due to innovations in stents such as the introduction of bioresorbable stents and stents developed with advanced materials to avoid restenosis. Moreover, the increasing number of angioplasties in countries such as China and India due to the large geriatric pool, high prevalence of cardiac disorders, and price capping are the main reasons which augment the stent segment growth.
Embolic protection devices garnered the largest share of the peripheral vascular devices market
The embolic protection devices segment accounted for the highest market share of the peripheral vascular device market. This is mainly attributed to the advantages of embolic protection devices over chronic total occlusion devices, such as the ability to capture embolic debris without interrupting continuous blood flow.
Based on geography, the study analyzes the peripheral vascular devices market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America dominated the global peripheral vascular devices market throughout the forecast period
North America recorded the largest market share in the peripheral vascular devices market, followed by Europe and Asia-Pacific. Factors that lead to an increase are the increasing prevalence of peripheral artery diseases, aortic aneurysms, and pulmonary embolisms; the rising number of obese & diabetic populations; and the presence of key players are leading the growth of this regional segment.
Asia-Pacific, on the other hand, is expected to be the most attractive regional peripheral vascular devices market due to a large presence of patients with unmet medical needs. Moreover, growth in healthcare infrastructure and patient disposable income levels in emerging markets, such as India and China, are expected to serve the overall market of peripheral vascular devices.
The global peripheral vascular devices market is highly competitive due to the presence of big brands. The key players operating in the peripheral vascular devices market are Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), B. Braun Melsungen AG (Germany), Blue Sail Medical Co., Ltd. (China), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), iVascular (Spain), Koninklijke Philips N.V. (Netherlands), Edwards Lifesciences Corporation (U.S.), Nipro Corporation (Japan), TE Connectivity LTD. (Switzerland), Medtronic Public Limited Company (Ireland), and Terumo Corporation (Japan), among others.
Overview: Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company is engaged in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on diabetes care, neuromodulation, diagnostics, nutrition & medicine. The company's product portfolio comprises FreeStyle, Pedialyte, EleCare, Juven, and Glucerna. These products are directly sold to distributors, wholesalers, pharmacies, health care facilities, government agencies, and independent retailers from company-owned distribution centers & public warehouses. The cardiovascular products further include MitraClip, Portico, Dilatation Catheter, among others. The diagnostics products include Vysis ALK, IntelliFISH, PathVysion, STARLIMS, AlinIQ, among others. The Company's headquarter is located in Illinois, United States.
Product Portfolio: The Company's portfolio comprises the therapeutic areas of cardiovascular, diabetes, diagnostics, neuromodulation, nutrition, and pharmaceuticals.
The global peripheral vascular devices market report would provide access to an approx: 52 market data table, 44 figures, and 210 pages.
LIST NOT EXHAUSTIVE